{"id":"supplementation-of-iron-sucrose","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypophosphatemia"},{"rate":null,"effect":"Hyperkalemia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL1200823","moleculeType":"Small molecule","molecularWeight":"398.14"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iron sucrose is a stable complex of iron (III) hydroxide with sucrose that delivers iron intravenously for rapid absorption and utilization by erythroid precursor cells. The iron is incorporated into hemoglobin and myoglobin, restoring oxygen-carrying capacity and correcting anemia. This formulation is particularly useful in patients who cannot tolerate oral iron or require rapid iron repletion, such as those with chronic kidney disease or heavy menstrual bleeding.","oneSentence":"Iron sucrose provides bioavailable iron to replenish depleted iron stores and restore hemoglobin synthesis in patients with iron deficiency anemia.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:10:09.976Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia in patients with chronic kidney disease"},{"name":"Iron deficiency anemia in patients intolerant to or non-responsive to oral iron therapy"}]},"trialDetails":[{"nctId":"NCT05385042","phase":"NA","title":"Iron and Immune Response to Vaccine (IRONMUM)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2022-06-18","conditions":"Pregnancy Related","enrollment":171},{"nctId":"NCT06970925","phase":"EARLY_PHASE1","title":"Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery","status":"RECRUITING","sponsor":"Englewood Hospital and Medical Center","startDate":"2025-06-30","conditions":"Cardiac Surgery","enrollment":40},{"nctId":"NCT06968936","phase":"NA","title":"Perioperative Blood Conservation: Role of Combined Iron Supplementation Protocols in Reducing Allogeneic Transfusion","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-05-15","conditions":"Anemia, Iron Deficiencies, Cardiac Surgery","enrollment":400},{"nctId":"NCT06012760","phase":"NA","title":"The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-04","conditions":"Anemia, Iron Deficiency Anemia, Perioperative","enrollment":400},{"nctId":"NCT06038656","phase":"NA","title":"Exercise and Galactooligosaccharide Supplementation on Inflammation and Iron Absorption (FexerGOS)","status":"COMPLETED","sponsor":"North-West University, South Africa","startDate":"2024-03-01","conditions":"Resistance Exercise","enrollment":22},{"nctId":"NCT05353348","phase":"NA","title":"Effect of the Combined Programme on Perioperative Anaemia（CPPA）","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-03-15","conditions":"Patient Blood Management, Cardiac Surgery, Iron Deficiency Anemia","enrollment":110},{"nctId":"NCT05489952","phase":"PHASE4","title":"Iron Supplementation for Geriatric Hip Fractures","status":"UNKNOWN","sponsor":"He Qifei","startDate":"2022-09-15","conditions":"Hip Fractures, Fragility Fracture, Osteoporotic Fractures","enrollment":444},{"nctId":"NCT04291690","phase":"NA","title":"The TARGET-EFT Randomized Clinical Trial","status":"COMPLETED","sponsor":"Jonathan Afilalo","startDate":"2020-03-05","conditions":"Frailty, Cardiovascular Diseases in Old Age, Geriatric Cardiology","enrollment":144},{"nctId":"NCT02198495","phase":"PHASE4","title":"Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2014-09","conditions":"Anemia of Chronic Kidney Disease","enrollment":143},{"nctId":"NCT04286984","phase":"","title":"Implementation of a Patient Blood Management Program in Gastric Cancer Surgery","status":"COMPLETED","sponsor":"Hospital Universitari de Bellvitge","startDate":"2014-01-01","conditions":"Gastric Cancer, Anemia, Iron Deficiency, Surgery--Complications","enrollment":1063},{"nctId":"NCT02941081","phase":"PHASE2","title":"A Novel Nano-iron Supplement to Safely Combat Iron Deficiency and Anaemia in Young Children: a Doubleblind Randomised Controlled Trial","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2018-01-08","conditions":"Iron Deficiency, Anaemia in Children","enrollment":645},{"nctId":"NCT02047552","phase":"PHASE2","title":"RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone","status":"WITHDRAWN","sponsor":"Denver Health and Hospital Authority","startDate":"2015-01","conditions":"Functional Iron Deficiency, Trauma, Anemia","enrollment":""},{"nctId":"NCT02743572","phase":"NA","title":"Iron-fortified Parenteral Nutrition in the Prevention and Treatment of Anemia in Premature Infants","status":"COMPLETED","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2015-09","conditions":"Premature Birth","enrollment":129},{"nctId":"NCT01180894","phase":"NA","title":"IV Iron for the Anemia of Traumatic Critical Illness","status":"COMPLETED","sponsor":"Denver Health and Hospital Authority","startDate":"2011-06","conditions":"Trauma, ICU Anemia","enrollment":150},{"nctId":"NCT02009943","phase":"PHASE1","title":"Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically Ill","status":"WITHDRAWN","sponsor":"Denver Health and Hospital Authority","startDate":"2017-02","conditions":"ICU Anemia, Functional Iron Deficiency","enrollment":""},{"nctId":"NCT02787824","phase":"PHASE4","title":"Periodic Versus Continuous IV Iron Supplementation in HD Patients","status":"COMPLETED","sponsor":"Papageorgiou General Hospital","startDate":"2016-05","conditions":"Anemia of Chronic Kidney Disease","enrollment":27},{"nctId":"NCT00960921","phase":"PHASE2","title":"Study of the Effects of Iron on Lung Blood Pressure at High Altitude","status":"WITHDRAWN","sponsor":"University of Oxford","startDate":"","conditions":"Hypertension, Pulmonary","enrollment":""},{"nctId":"NCT01265108","phase":"PHASE1","title":"Effects of Iron on Exercise Capacity During Hypoxia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2010-11","conditions":"Healthy Volunteers","enrollment":12},{"nctId":"NCT00482716","phase":"PHASE3","title":"Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer","status":"UNKNOWN","sponsor":"St. Bartholomew's Hospital","startDate":"2007-01","conditions":"Anemia, Leukemia, Lymphoma","enrollment":80},{"nctId":"NCT00661999","phase":"PHASE3","title":"Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2006-01","conditions":"Anemia, Leukemia, Lymphoma","enrollment":502},{"nctId":"NCT00557817","phase":"PHASE2, PHASE3","title":"Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)","status":"COMPLETED","sponsor":"University of Liege","startDate":"2004-03","conditions":"Hematological Malignancies","enrollment":125},{"nctId":"NCT00952302","phase":"NA","title":"Study of the Effects of Iron Levels on the Lungs at High Altitude","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2008-10","conditions":"Pulmonary Hypertension, Mountain Sickness","enrollment":33},{"nctId":"NCT00210002","phase":"PHASE2","title":"Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced","status":"TERMINATED","sponsor":"Institut Claudius Regaud","startDate":"2003-11","conditions":"Neoplasms, Anemia","enrollment":55},{"nctId":"NCT00386126","phase":"PHASE2, PHASE3","title":"Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2006-08","conditions":"Heart Failure, Anemia","enrollment":117},{"nctId":"NCT00125996","phase":"PHASE1, PHASE2","title":"Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure","status":"UNKNOWN","sponsor":"National Heart and Lung Institute","startDate":"2004-07","conditions":"Chronic Heart Failure, Heart Diseases, Anemia, Iron-Deficiency","enrollment":42}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":125,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Supplementation of iron sucrose","genericName":"Supplementation of iron sucrose","companyName":"Medical University of Vienna","companyId":"medical-university-of-vienna","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iron sucrose provides bioavailable iron to replenish depleted iron stores and restore hemoglobin synthesis in patients with iron deficiency anemia. Used for Iron deficiency anemia in patients with chronic kidney disease, Iron deficiency anemia in patients intolerant to or non-responsive to oral iron therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}